Iconic Therapeutics, Inc.

Iconic Therapeutics, Inc. (Iconic) is a development stage company, engaged in the development and commercialization of immunoconjugate proteins to treat adult macular degeneration and many cancers. Iconic is mainly focused on developing novel immunoconjugate proteins (I-cons), which trigger the immune system to target and destroy unwanted cells in the body. Iconic has negotiated a worldwide exclusive license with Yale University with respect to I-con1 and the I-con technology. The company is headquartered at Atlanta in Georgia, the US.

Street: 
127 Peachtree Street, N.E.
City: 
Atlanta
Postcode: 
30303
Federal State : 
United States
WebSite: 
www.iconictherapeutics.com
Fax: 
1-404-5226366

Company Index Score

Current Index Score Historical Index Score
  • Iconic Therapeutics, Inc. currently scores 50 % in the index.
  • Iconic Therapeutics, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Iconic Therapeutics, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets